 PHILADELPHIA, Nov. 04, 2020 GLOBE NEWSWIRE -- Passage Bio, Inc. NASDAQ: PASG, a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system disorders, today announced that it will host a conference call and live webcast at 8:30 a.m. ET on Tuesday, November 10, 2020 to report its third quarter 2020 financial results and discuss recent business highlights. 